{
  "ticker": "LLY",
  "target_date": "2025-02-17",
  "actual_date": "2025-02-14",
  "collected_at": "2025-12-08T11:24:49.549378",
  "price": {
    "open": 864.15,
    "high": 868.53,
    "low": 836.7,
    "close": 839.4636840820312,
    "volume": 3222300,
    "change_1d_pct": -3.0,
    "change_7d_pct": 0.42,
    "change_30d_pct": 9.55
  },
  "technicals": {
    "rsi_14": 62.32,
    "sma_20": 812.81,
    "sma_50": 792.86,
    "macd": 23.842,
    "macd_signal": 20.4,
    "macd_histogram": 3.442,
    "bb_upper": 905.18,
    "bb_lower": 720.44,
    "price_vs_sma20_pct": 3.28,
    "price_vs_sma50_pct": 5.88,
    "volume_ratio": 0.9
  },
  "fundamentals": {
    "market_cap": 891443806208,
    "pe_ratio": 48.721607,
    "forward_pe": 43.88385,
    "price_to_book": 37.440063,
    "price_to_sales": 15.002471,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.57,
    "pct_from_52w_low": 59.42
  },
  "macro": {
    "spy": {
      "price": 604.4,
      "change_1d_pct": -0.0,
      "change_7d_pct": 0.56
    },
    "vix": {
      "level": 14.77,
      "signal": "LOW_FEAR"
    },
    "treasury_10y": {
      "yield_pct": 4.47
    },
    "dollar_index": {
      "level": 106.57
    },
    "gold": {
      "price": 2883.6
    },
    "regime": "BULL_NORMAL"
  },
  "news": [
    {
      "headline": "Parnassus Core Equity Fund Q4 And Annual 2024 Investment Commentary",
      "source": "SeekingAlpha",
      "datetime": 1739770500,
      "summary": "The Parnassus Core Equity Fund returned 0.28% (net of fees) for the quarter, underperforming the S&P 500 Index\u00e2\u0080\u0099s 2.41%. Click here to read the full commentary. ",
      "url": "https://finnhub.io/api/news?id=a4aff68571cfd19f93df65ce183c68ea191d09d1690c4e73b2cf4f1edb4cf3b9"
    },
    {
      "headline": "Why Regeneron's Price May Soon Break Out",
      "source": "SeekingAlpha",
      "datetime": 1739742843,
      "summary": "Regeneron Pharmaceuticals' fourth quarter results beat my and Wall Street analysts' expectations. See why REGN stock is a top pick for long-term investors.",
      "url": "https://finnhub.io/api/news?id=d5af37c15f7937cb7659c25bbaefc15e6d819270430ea1e30992e3c141a5a315"
    },
    {
      "headline": "IXJ: Healthcare Sector\u00a0Dashboard For February",
      "source": "SeekingAlpha",
      "datetime": 1739668261,
      "summary": "The healthcare sector is currently overvalued by about 13% relative to 11-year averages. Check out the top-down analysis of the healthcare sector.",
      "url": "https://finnhub.io/api/news?id=3fe84321680f6b9bc73edbfeb6fdc9d12ca422114c4b592cc6993ea621d7efe7"
    },
    {
      "headline": "Janus Henderson Research Fund Q4 2024 Commentary",
      "source": "SeekingAlpha",
      "datetime": 1739586600,
      "summary": "The Janus Henderson Research Fund returned 5.54% and the Russell 1000\u00c2\u00ae Growth Index returned 7.07% for Q4 2024. Click here to read the full commentary. ",
      "url": "https://finnhub.io/api/news?id=bc69e3761d19663beb10bd78fcdca41f75bf30dfcffc9d4264b73921fa2a229e"
    },
    {
      "headline": "Eli Lilly & Co. stock underperforms Friday when compared to competitors",
      "source": "MarketWatch",
      "datetime": 1739550660,
      "summary": "Eli Lilly & Co. stock underperforms Friday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=a6d2c179df1791c3e58fce975883788830dcb84c21d1137b4f514bd5039806d1"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-02-14",
      "description": "xslF345X05/form4-02142025_040201.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000141588925004090/xslF345X05/form4-02142025_040201.xml"
    },
    {
      "form": "4",
      "date": "2025-02-12",
      "description": "xslF345X05/wk-form4_1739395815.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000061/xslF345X05/wk-form4_1739395815.xml"
    },
    {
      "form": "4",
      "date": "2025-02-12",
      "description": "xslF345X05/wk-form4_1739395756.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000059/xslF345X05/wk-form4_1739395756.xml"
    },
    {
      "form": "4",
      "date": "2025-02-12",
      "description": "xslF345X05/wk-form4_1739395681.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000057/xslF345X05/wk-form4_1739395681.xml"
    },
    {
      "form": "4",
      "date": "2025-02-12",
      "description": "xslF345X05/wk-form4_1739395622.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000055/xslF345X05/wk-form4_1739395622.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}